C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in…
GSMA calls for renewed focus on closing the Usage Gap as more than 3 billion people remain offline despite available mobile internet services
LONDON, Sept. 9, 2025 /PRNewswire/ -- 4.7 billion people, or 58% of…
The National Geographic Society and PepsiCo Launch New Food for Tomorrow Program Focused on Regenerative Agriculture
WASHINGTON, Sept. 4, 2025 /PRNewswire/ -- Today, the National Geographic Society and…
Africa Wealth Report 2025: Continent Outpaces Global Growth as New Wealth Hubs Surge
LONDON, Aug. 26, 2025 /PRNewswire/ -- Africa's millionaire population is projected to…
Aon Announces Strategic Investment in eMed to Scale GLP-1 Population Health Platform
Strategic investment is accelerating the transformation of employer-focused obesity solutions to boost…
New APOE4 App Uses AI Digital Twins to Help 25% of Population at High Alzheimer’s Risk
Phoenix platform matches users with genetically similar people to predict which interventions…
India’s Urban Population to Reach 600 Million by 2036: Primus Partners Report
Urbanization on the Rise: India's urbanization rate, which stood at 31% in…
AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer
PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3…
RP1 Launches the Worlds First Metaverse Browser
Immersive demo at AWE USA 2025, showcasing breakthrough technologies that can connect…
